Patents by Inventor Prosper Boyaka

Prosper Boyaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods to improve induction of IgA antibodies by vaccines
    Patent number: 10286068
    Abstract: A vaccine composition is disclosed that contains a vaccine antigen and a neutrophil inhibitor in amounts effective to promote an IgA response to the antigen in a subject. Also disclosed is a method for enhancing immune response to a vaccine antigen in a subject that involves co-administering to the subject the vaccine antigen and an adjuvant composition comprising a neutrophil inhibitor in an amount effective to promote an IgA response to the vaccine antigen in the subject.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 14, 2019
    Assignee: Ohio State Innovation Foundation
    Inventor: Prosper Boyaka
  • METHODS TO IMPROVE INDUCTION OF IGG AND IGA ANTIBODIES BY VACCINES
    Publication number: 20180360953
    Abstract: A vaccine composition is disclosed that contains a vaccine antigen and a neutrophil inhibitor in amounts effective to promote an IgA and/or an IgG response to the antigen in a subject. Also disclosed is a method for enhancing immune response to a vaccine antigen in a subject that involves co-administering to the subject the vaccine antigen and an adjuvant composition comprising a neutrophil inhibitor in an amount effective to promote an IgA and/or IgG response to the vaccine antigen in the subject.
    Type: Application
    Filed: April 3, 2018
    Publication date: December 20, 2018
    Inventors: Prosper Boyaka, Estelle Cormet-Boyaka
  • METHODS TO IMPROVE INDUCTION OF IGA ANTIBODIES BY VACCINES
    Publication number: 20180099043
    Abstract: A vaccine composition is disclosed that contains a vaccine antigen and a neutrophil inhibitor in amounts effective to promote an IgA response to the antigen in a subject. Also disclosed is a method for enhancing immune response to a vaccine antigen in a subject that involves co-administering to the subject the vaccine antigen and an adjuvant composition comprising a neutrophil inhibitor in an amount effective to promote an IgA response to the vaccine antigen in the subject.
    Type: Application
    Filed: April 15, 2016
    Publication date: April 12, 2018
    Inventor: Prosper BOYAKA
  • Sialidases as mucosal adjuvants
    Publication number: 20020025320
    Abstract: Organisms or proteins may be administered in conjunction with sialidases in a pharmaceutically acceptable carrier to heighten immune response. When sialidase is used in conjunction with an antibody to a CD43 molecule, the immune response-enhancing properties of the sialidases are further potentiated in a synergistic manner. The mucosal routes of administration include oral, nasal, rectal and vaginal routes.
    Type: Application
    Filed: June 25, 2001
    Publication date: February 28, 2002
    Inventors: Prosper Boyaka, Mariarosaria Marinaro